FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2148936706> ?p ?o ?g. }

• W2148936706 endingPage "259" @default.
• W2148936706 startingPage "250" @default.
• W2148936706 abstract "Objectives. Elevated expression of Siglec-1 on circulating monocytes has been reported in some inflammatory and autoimmune diseases, but its expression and role in RA has not been elucidated. The aims of this study were to determine the expression of Siglec-1 in peripheral blood and to explore its role in mononuclear cell reactivity to autoantigen in RA. Methods. Siglec-1 protein and mRNA levels in 42 RA patients, 39 OA patients, 28 SLE patients and 42 normal controls were determined by flow cytometry and quantitative RT-PCR, respectively. In addition, 10 patients with active RA received DMARDs for 12 weeks and the frequencies of Siglec-1-positive cells and the 28-joint DAS (DAS28) were assessed before and after therapy. Furthermore, TNF-α, IFN-γ and type II collagen were used to up-regulate Siglec-1. Peripheral blood mononuclear cells (PBMCs) from different groups were stimulated with mitogens or antigens and cell proliferation and cytokine production were determined. Results. The protein and mRNA levels of Siglec-1 on PBMCs and monocytes in RA patients were significantly higher than those in OA patients and healthy controls. Moreover, the expression of Siglec-1 protein on PBMCs was positively correlated with DAS28, ESR, high-sensitivity CRP and IgM-RF, but not with anti-CCP antibody. Interestingly, Siglec-1 expression was decreased in parallel with the decrease in the DAS28 after 12 weeks of anti-rheumatic treatment. Furthermore, TNF-α, IFN-γ and type II collagen can up-regulate Siglec-1 in PBMCs. Elevated PBMC proliferation and proinflammatory cytokine production to collagen stimulation in RA patients decreased when Siglec-1 was inhibited by anti-Siglec-1 antibodies. Conclusion. Elevated Siglec-1 expression in PBMCs and monocytes can potentially serve as a biomarker for monitoring disease activity in RA. Siglec-1 may also play a proinflammatory role in stimulating lymphocyte proliferation and activation in RA." @default.
• W2148936706 created "2016-06-24" @default.
• W2148936706 creator A5021491996 @default.
• W2148936706 creator A5023022659 @default.
• W2148936706 creator A5030574173 @default.
• W2148936706 creator A5046713483 @default.
• W2148936706 creator A5062452095 @default.
• W2148936706 creator A5065251949 @default.
• W2148936706 creator A5071737859 @default.
• W2148936706 creator A5087498533 @default.
• W2148936706 creator A5088992844 @default.
• W2148936706 date "2013-11-05" @default.
• W2148936706 modified "2023-10-06" @default.
• W2148936706 title "Increased expression of Siglec-1 on peripheral blood monocytes and its role in mononuclear cell reactivity to autoantigen in rheumatoid arthritis" @default.
• W2148936706 cites W1968858193 @default.
• W2148936706 cites W1969119554 @default.
• W2148936706 cites W1971907885 @default.
• W2148936706 cites W1983425323 @default.
• W2148936706 cites W2003922100 @default.
• W2148936706 cites W2006194219 @default.
• W2148936706 cites W2019582534 @default.
• W2148936706 cites W2026578487 @default.
• W2148936706 cites W2027225108 @default.
• W2148936706 cites W2028200430 @default.
• W2148936706 cites W2035934024 @default.
• W2148936706 cites W2053572419 @default.
• W2148936706 cites W2069978881 @default.
• W2148936706 cites W2075853683 @default.
• W2148936706 cites W2080439732 @default.
• W2148936706 cites W2081057881 @default.
• W2148936706 cites W2092393505 @default.
• W2148936706 cites W2094596462 @default.
• W2148936706 cites W2097906920 @default.
• W2148936706 cites W2098919737 @default.
• W2148936706 cites W2100382163 @default.
• W2148936706 cites W2103394009 @default.
• W2148936706 cites W2107277218 @default.
• W2148936706 cites W2110177517 @default.
• W2148936706 cites W2130531305 @default.
• W2148936706 cites W2132536379 @default.
• W2148936706 cites W2146203649 @default.
• W2148936706 cites W2148300799 @default.
• W2148936706 cites W2152348310 @default.
• W2148936706 cites W2156013098 @default.
• W2148936706 cites W2158550197 @default.
• W2148936706 cites W2338102355 @default.
• W2148936706 doi "https://doi.org/10.1093/rheumatology/ket342" @default.
• W2148936706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24196391" @default.
• W2148936706 hasPublicationYear "2013" @default.
• W2148936706 type Work @default.
• W2148936706 sameAs 2148936706 @default.
• W2148936706 citedByCount "44" @default.
• W2148936706 countsByYear W21489367062014 @default.
• W2148936706 countsByYear W21489367062015 @default.
• W2148936706 countsByYear W21489367062016 @default.
• W2148936706 countsByYear W21489367062017 @default.
• W2148936706 countsByYear W21489367062018 @default.
• W2148936706 countsByYear W21489367062019 @default.
• W2148936706 countsByYear W21489367062020 @default.
• W2148936706 countsByYear W21489367062021 @default.
• W2148936706 countsByYear W21489367062022 @default.
• W2148936706 countsByYear W21489367062023 @default.
• W2148936706 crossrefType "journal-article" @default.
• W2148936706 hasAuthorship W2148936706A5021491996 @default.
• W2148936706 hasAuthorship W2148936706A5023022659 @default.
• W2148936706 hasAuthorship W2148936706A5030574173 @default.
• W2148936706 hasAuthorship W2148936706A5046713483 @default.
• W2148936706 hasAuthorship W2148936706A5062452095 @default.
• W2148936706 hasAuthorship W2148936706A5065251949 @default.
• W2148936706 hasAuthorship W2148936706A5071737859 @default.
• W2148936706 hasAuthorship W2148936706A5087498533 @default.
• W2148936706 hasAuthorship W2148936706A5088992844 @default.
• W2148936706 hasConcept C137061746 @default.
• W2148936706 hasConcept C147483822 @default.
• W2148936706 hasConcept C159654299 @default.
• W2148936706 hasConcept C164027704 @default.
• W2148936706 hasConcept C17991360 @default.
• W2148936706 hasConcept C202751555 @default.
• W2148936706 hasConcept C203014093 @default.
• W2148936706 hasConcept C2776090121 @default.
• W2148936706 hasConcept C2776914184 @default.
• W2148936706 hasConcept C2777575956 @default.
• W2148936706 hasConcept C2778017598 @default.
• W2148936706 hasConcept C2778690821 @default.
• W2148936706 hasConcept C2781184567 @default.
• W2148936706 hasConcept C55493867 @default.
• W2148936706 hasConcept C71924100 @default.
• W2148936706 hasConcept C86803240 @default.
• W2148936706 hasConcept C8891405 @default.
• W2148936706 hasConceptScore W2148936706C137061746 @default.
• W2148936706 hasConceptScore W2148936706C147483822 @default.
• W2148936706 hasConceptScore W2148936706C159654299 @default.
• W2148936706 hasConceptScore W2148936706C164027704 @default.
• W2148936706 hasConceptScore W2148936706C17991360 @default.
• W2148936706 hasConceptScore W2148936706C202751555 @default.
• W2148936706 hasConceptScore W2148936706C203014093 @default.
• W2148936706 hasConceptScore W2148936706C2776090121 @default.
• W2148936706 hasConceptScore W2148936706C2776914184 @default.

• next